Nasdaq: MRVLMarvell Technology
Marvell Technology agrees to merge with Lumentum in a 4.5-for-1 share deal
- US stocks
- Agreement
- Information Technology

Marvell Technology (Nasdaq: MRVL) agreed to merge with Lumentum Holdings Inc., giving each Lumentum common share 4.500 Marvell common shares, it said on 2 Nov 2026. The merger agreement, entered into 1 Nov 2026, sets a $5.8 billion termination fee that Marvell pays in specified cases. Lumentum would become a wholly owned Marvell subsidiary if the deal closes.
Key highlights
- Exchange ratio: 4.500 Marvell common shares per Lumentum common share
- Marvell termination fee: $5.8 billion
- Lumentum termination fee: $2.9 billion
- Regulatory termination fee: $3.2 billion
- Outside date: 1 Nov 2027
The deal in numbers
| Item | Detail |
|---|---|
| Parties | Marvell Technology and Lumentum Holdings Inc. |
| Exchange ratio | 4.500 Marvell common shares per Lumentum common share, with cash in lieu of fractional shares |
| Lumentum Series A preferred | Marvell common shares, or one Marvell Series B preferred share if the holder makes that election |
| Marvell termination fee | $5.8 billion |
| Lumentum termination fee | $2.9 billion |
| Regulatory termination fee | $3.2 billion, payable by Marvell in certain cases |
| Board seats after closing | Three Lumentum-designated directors join the Marvell Board |
| Outside date | 11:59 p.m. Pacific Time, 1 Nov 2027 |
| Listing | Marvell common stock on the Nasdaq Global Select Market |
Lumentum holders would receive Marvell stock
Under the merger agreement, each share of Lumentum common stock converts into 4.500 shares of Marvell common stock, with cash paid instead of fractional shares. Lumentum Series A preferred holders receive Marvell common stock based on the common shares their preferred converts into, unless they elect Marvell Series B Convertible Preferred Stock, which the filing says is intended to have the same terms as the Lumentum Series A preferred. Lumentum stock options, restricted stock units and performance stock units convert into Marvell awards at the same ratio, and performance stock units become time-vesting restricted stock units only.
The deal runs in two steps: a Marvell subsidiary merges into Lumentum, and Lumentum then merges into a second Marvell subsidiary. Immediately after the effective time, Marvell will appoint three directors designated by Lumentum to the Marvell Board.
Approvals and conditions remain before closing
Completion depends on approval by Lumentum stockholders and by Marvell stockholders of the share issuance and a charter amendment that increases Marvell's authorized common shares. The Marvell Board unanimously approved the agreement and recommended that Marvell stockholders approve those two items.
Other conditions include the end of the waiting period under the Hart-Scott-Rodino Act, certain other regulatory approvals, effectiveness of a Form S-4 registration statement, and Nasdaq authorization to list the new shares. The outside date is 11:59 p.m. Pacific Time on 1 Nov 2027, which can be extended to 1 Aug 2028 in certain regulatory cases.
Termination fees run in both directions
Marvell would pay Lumentum a termination fee of $5.8 billion if the Marvell Board withdraws its recommendation, or if Marvell terminates the agreement to accept a superior proposal. Marvell also owes that fee in certain cases where an alternative deal for Marvell is agreed or completed within twelve months of termination. Lumentum owes Marvell $2.9 billion in corresponding circumstances.
A separate $3.2 billion regulatory termination fee is payable by Marvell in certain terminations, including a failure to close by the outside date or a final legal restraint under antitrust or foreign investment laws.
What the Marvell and Lumentum merger means for shareholders
For Lumentum shareholders, each common share converts into 4.500 Marvell shares, so the value received depends on Marvell's share price at closing, which the filing does not state. For Marvell shareholders, the deal depends on their approval of the share issuance and the charter amendment.
The filing does not say when the deal is expected to close, the total value of the transaction, or how it affects either company's results. The companies plan to file a Form S-4 with a joint proxy statement, and the outside date is 1 Nov 2027.
Filed with the US SEC on . Reference: Original filing (SEC)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
Figures are from the company's filings with the US Securities and Exchange Commission and are in US dollars. Investing in US stocks from India is subject to the Liberalised Remittance Scheme, currency risk and taxes in both countries.

